Eva Catalá is a Global Development Medical Director at AstraZeneca, having started in 2025. Previously, they served as an attending physician and hematologist at Hospital Gregorio Marañón from 2022 to 2024, and completed a hematology fellowship at Vall d'Hebron Barcelona Hospital Campus from 2018 to 2022. Eva also held a position as a Clinical Research Fellow in the Immune Effector Cell Program at Dana-Farber Cancer Institute from 2024 to 2025. They obtained a degree in medicine from Universitat Jaume I, graduating in 2017.
This person is not in any teams
This person is not in any offices